219 related articles for article (PubMed ID: 30692625)
1. AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions.
Guo J; Dai X; Laurent B; Zheng N; Gan W; Zhang J; Guo A; Yuan M; Liu P; Asara JM; Toker A; Shi Y; Pandolfi PP; Wei W
Nat Cell Biol; 2019 Feb; 21(2):226-237. PubMed ID: 30692625
[TBL] [Abstract][Full Text] [Related]
2. SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.
Wang G; Long J; Gao Y; Zhang W; Han F; Xu C; Sun L; Yang SC; Lan J; Hou Z; Cai Z; Jin G; Hsu CC; Wang YH; Hu J; Chen TY; Li H; Lee MG; Lin HK
Nat Cell Biol; 2019 Feb; 21(2):214-225. PubMed ID: 30692626
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
4. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
[TBL] [Abstract][Full Text] [Related]
5. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
[TBL] [Abstract][Full Text] [Related]
6. PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
Yin S; Liu L; Brobbey C; Palanisamy V; Ball LE; Olsen SK; Ostrowski MC; Gan W
Nat Commun; 2021 Jun; 12(1):3444. PubMed ID: 34103528
[TBL] [Abstract][Full Text] [Related]
7. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
[TBL] [Abstract][Full Text] [Related]
8. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase SETDB1 maintains survival of mouse spermatogonial stem/progenitor cells via PTEN/AKT/FOXO1 pathway.
Liu T; Chen X; Li T; Li X; Lyu Y; Fan X; Zhang P; Zeng W
Biochim Biophys Acta Gene Regul Mech; 2017 Oct; 1860(10):1094-1102. PubMed ID: 28890329
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
11. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN.
Nakakido M; Deng Z; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Neoplasia; 2015 Apr; 17(4):367-73. PubMed ID: 25925379
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
14. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
15. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic AKTivation by methylation.
Luciano AK; Guertin DA
Nat Cell Biol; 2019 Feb; 21(2):114-115. PubMed ID: 30692624
[No Abstract] [Full Text] [Related]
17. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.
Sundaresan NR; Pillai VB; Wolfgeher D; Samant S; Vasudevan P; Parekh V; Raghuraman H; Cunningham JM; Gupta M; Gupta MP
Sci Signal; 2011 Jul; 4(182):ra46. PubMed ID: 21775285
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
19. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.
Cha TL; Zhou BP; Xia W; Wu Y; Yang CC; Chen CT; Ping B; Otte AP; Hung MC
Science; 2005 Oct; 310(5746):306-10. PubMed ID: 16224021
[TBL] [Abstract][Full Text] [Related]
20. AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis.
Sun Z; Jiang Q; Gao B; Zhang X; Bu L; Wang L; Lin Y; Xie W; Li J; Guo J
Cancer Res; 2023 Apr; 83(8):1264-1279. PubMed ID: 36806887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
